Methyl 2-Benzamido-1-(3-Phenylpropyl)-1H-Benzo[D]Imidazole-5-Carboxylate 2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[d]咪唑-5-羧酸甲酯
CAS 1374601-40-7 MFCD474601407
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
产品应用
- BRD4770 is a novel histone methyltransferase inhibitor. BRD4770 reduced cellular levels of di- and trimethylated H3K9 without inducing apoptosis, induced senescence, and inhibited both anchorage-dependent and -independent proliferation in the pancreatic cancer cell line PANC-1. ATM-pathway activation, caused by either genetic or small-molecule inhibition of G9a, may mediate BRD4770-induced cell senescence. BRD4770 may be a useful tool to study G9a and its role in senescence and cancer cell biology.